Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development
Authors
Keywords
-
Journal
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
Volume 40, Issue 7, Pages 1368-1379
Publisher
Wiley
Online
2016-05-17
DOI
10.1111/acer.13093
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Existing and Future Drugs for the Treatment of the Dark Side of Addiction
- (2016) George F. Koob et al. Annual Review of Pharmacology and Toxicology
- From genetic studies to precision medicine in alcohol dependence
- (2016) Yan Sun et al. BEHAVIOURAL PHARMACOLOGY
- Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders
- (2016) Laura E. Kwako et al. BIOLOGICAL PSYCHIATRY
- Model-free functional connectivity and impulsivity correlates of alcohol dependence: a resting-state study
- (2015) Xi Zhu et al. ADDICTION BIOLOGY
- Using Transdermal Alcohol Monitoring to Detect Low-Level Drinking
- (2015) John D. Roache et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- The Pharmacogenetics of Alcohol Use Disorder
- (2015) Jermaine D. Jones et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Heterogeneity of Alcohol Use Disorder: Understanding Mechanisms to Advance Personalized Treatment
- (2015) Raye Z. Litten et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Guidelines for the Reporting of Treatment Trials for Alcohol Use Disorders
- (2015) Katie Witkiewitz et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Subgroup Identification in Personalized Treatment of Alcohol Dependence
- (2015) Jue Hou et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- 2010 National and State Costs of Excessive Alcohol Consumption
- (2015) Jeffrey J. Sacks et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Optogenetics and the Circuit Dynamics of Psychiatric Disease
- (2015) Karl Deisseroth et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence
- (2015) Daniel E. Falk et al. Journal of Addiction Medicine
- BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders
- (2015) Christian R. Schubert et al. NEURON
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Soft, Injectable Electronic Probes for the Brain
- (2015) Seth Fletcher SCIENTIFIC AMERICAN
- Naltrexone vs Placebo for the Treatment of Alcohol Dependence
- (2015) David W. Oslin et al. JAMA Psychiatry
- Epidemiology ofDSM-5Alcohol Use Disorder
- (2015) Bridget F. Grant et al. JAMA Psychiatry
- The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence
- (2015) P Suchankova et al. Translational Psychiatry
- Dissemination, Adoption, and Implementation of Acamprosate for Treating Alcohol Use Disorders
- (2015) Hannah K Knudsen et al. Journal of Studies on Alcohol and Drugs
- Cumulative Proportion of Responders Analysis (CPRA) as a Tool to Assess Treatment Outcome in Alcohol Clinical Trials
- (2015) Daniel E Falk et al. Journal of Studies on Alcohol and Drugs
- Commentary on Garbuttet al. (2014): Can we predict who benefits from naltrexone in the treatment of alcohol dependence?
- (2014) Henry R. Kranzler ADDICTION
- Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence
- (2014) James C. Garbutt et al. ADDICTION
- Methods to Analyze Treatment Effects in the Presence of Missing Data for a Continuous Heavy Drinking Outcome Measure When Participants Drop Out from Treatment in Alcohol Clinical Trials
- (2014) Katie Witkiewitz et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Predicting Naltrexone Response in Alcohol-Dependent Patients: The Contribution of Functional Magnetic Resonance Imaging
- (2014) Karl Mann et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Topiramate Treatment for Heavy Drinkers: Moderation by aGRIK1Polymorphism
- (2014) Henry R. Kranzler et al. AMERICAN JOURNAL OF PSYCHIATRY
- iPS cells: a game changer for future medicine
- (2014) H. Inoue et al. EMBO JOURNAL
- Combining diffusion tensor imaging and magnetic resonance spectroscopy to study reduced frontal white matter integrity in youths with family histories of substance use disorders
- (2014) Ashley Acheson et al. HUMAN BRAIN MAPPING
- Pathological circuit function underlying addiction and anxiety disorders
- (2014) Andreas Lüthi et al. NATURE NEUROSCIENCE
- How the Affordable Care Act and Mental Health Parity and Addiction Equity Act Greatly Expand Coverage of Behavioral Health Care
- (2014) Kirsten Beronio et al. JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH
- Concise Review: Drug Discovery in the Age of the Induced Pluripotent Stem Cell
- (2014) Huaising C. Ko et al. Stem Cells Translational Medicine
- Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate
- (2014) V M Karpyak et al. Translational Psychiatry
- Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence
- (2013) Richard L. Bell et al. ADDICTION BIOLOGY
- Research Opportunities for Medications to Treat Alcohol Dependence: Addressing Stakeholders' Needs
- (2013) Raye Z. Litten et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- The Placebo Effect in Clinical Trials for Alcohol Dependence: An Exploratory Analysis of 51 Naltrexone and Acamprosate Studies
- (2013) Raye Z. Litten et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Determination of Genotype Combinations That Can Predict the Outcome of the Treatment of Alcohol Dependence Using the 5-HT3Antagonist Ondansetron
- (2013) Bankole A. Johnson et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence
- (2013) Raye Z. Litten et al. Journal of Addiction Medicine
- CLARITY for mapping the nervous system
- (2013) Kwanghun Chung et al. NATURE METHODS
- The NIH BRAIN Initiative
- (2013) T. R. Insel et al. SCIENCE
- Medications development to treat alcohol dependence: a vision for the next decade
- (2012) Raye Z. Litten et al. ADDICTION BIOLOGY
- A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Levetiracetam Extended-Release in Very Heavy Drinking Alcohol-Dependent Patients
- (2012) Joanne B. Fertig et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Human Laboratory Paradigms in Alcohol Research
- (2012) Jennifer G. Plebani et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies
- (2011) Yuri A. Blednov et al. ADDICTION BIOLOGY
- A Double-Blind, Placebo-Controlled Trial to Assess the Efficacy of Quetiapine Fumarate XR in Very Heavy-Drinking Alcohol-Dependent Patients
- (2011) Raye Z. Litten et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Pharmacogenetic Approach at the Serotonin Transporter Gene as a Method of Reducing the Severity of Alcohol Drinking
- (2011) Bankole A. Johnson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Neuroimmune mechanisms of brain function and alcohol related disorders
- (2011) Changhai Cui et al. BRAIN BEHAVIOR AND IMMUNITY
- The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use Disorders
- (2011) Raymond F Anton et al. NEUROPSYCHOPHARMACOLOGY
- A Dearth of New Meds
- (2011) Kenneth I. Kaitin et al. SCIENTIFIC AMERICAN
- Percentage of Subjects With No Heavy Drinking Days: Evaluation as an Efficacy Endpoint for AlcoholClinical Trials
- (2010) Daniel Falk et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Alcohol Biomarkers in Applied Settings: Recent Advances and Future Research Opportunities
- (2010) Raye Z. Litten et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate
- (2010) F Kiefer et al. PHARMACOGENOMICS JOURNAL
- Development of pharmacotherapies for drug addiction: a Rosetta Stone approach
- (2009) George F. Koob et al. NATURE REVIEWS DRUG DISCOVERY
- Impulsivity as a determinant and consequence of drug use: a review of underlying processes
- (2008) Harriet de Wit ADDICTION BIOLOGY
- Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty
- (2008) Tami L. Mark et al. DRUG AND ALCOHOL DEPENDENCE
- A Role for Brain Stress Systems in Addiction
- (2008) George F. Koob NEURON
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started